Krawczyk M, Liebe R, Maier IB, Engstler AJ, Lammert F, Bergheim I
the peptide Ac-Nle-cyc/o(- Asp-His-D-Phe-Arg-Trp-Lys)-OH is used in the manufacture of a medicament for intranasal administration for use in the treatment of erectile dysfunction in a male, wherein the peptide Ac-Nle- cyc/o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH increases cGMP levels to an amount sufficient to produce an erection sufficient for sexual intercourse when the peptide Ac-Nle-cyc/o(-Asp-His-D-Phe-Arg-Trp- Lys)-OH is administered at a sub-therapeutic dose and administered subsequent to a sub- therapeutic dose of a PDE-5 inhibitor
ET today to discuss the FDA approval of IMCIVREE for patients with acquired HO
The clearance of salicylates may be increased with concurrent use of corticosteroids
That was true for fewer than 7% of semaglutide users who lost the same percentage of body weight
With millions more people struggling with obesity than diabetes, the financial incentive to market GLP-1s as a weight-loss solution is undeniable